Related Experiment Video
Updated: Mar 17, 2026

Single Cell Measurement of Dopamine Release with Simultaneous Voltage-clamp and Amperometry
Published on: November 21, 2012
Stimulants and Athletic Performance (Part 1 of 2): Amphetamines and Caffeine
Athletes often use amphetamines and caffeine to combat fatigue, but their performance effects and health risks remain unclear. Both substances carry significant health concerns and are regulated in sports.
Area of Science:
- Sports Science
- Pharmacology
- Exercise Physiology
Background:
- Athletes frequently use stimulants like amphetamines and caffeine to enhance athletic performance and reduce fatigue.
- The physiological effects and ergogenic potential of these substances are not fully understood.
- Both amphetamines and caffeine carry potential health risks and are subject to anti-doping regulations.
Purpose of the Study:
- To investigate the unclear effects of amphetamines and caffeine on athletic performance.
- To highlight the potential health risks associated with stimulant use in athletes.
- To inform about the regulatory status of these substances in sports.
Main Methods:
- Review of existing literature on stimulant effects on athletic performance.
- Analysis of physiological mechanisms of action for amphetamines and caffeine.
- Examination of anti-doping regulations concerning banned substances.
Main Results:
- Amphetamines impact the central nervous system (CNS), potentially causing adverse effects like anxiety, insomnia, and fever.
- Caffeine may enhance fatty acid utilization, mask fatigue via CNS stimulation, and increase muscle contraction force.
- Amphetamines are completely banned by the International Olympic Committee (IOC).
Conclusions:
- The use of amphetamines and caffeine by athletes presents unclear performance benefits alongside significant health risks.
- Caffeine is banned by the IOC if urine concentrations exceed 15 μ g·ml(-1).
- Athletes should be aware of the potential dangers and regulatory restrictions surrounding stimulant use.
More Related Videos
10:02Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD
Published on: March 12, 2020
07:56A Plate-Based Assay for the Measurement of Endogenous Monoamine Release in Acute Brain Slices
Published on: August 11, 2021
Related Concept Videos
Adrenergic Agonists: Mixed-Action Agents
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
Adrenergic Agonists: Indirect-Acting Agents
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
Adrenergic Agonists: Therapeutic Uses
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists